836 results on '"Zeng Mu-Sheng"'
Search Results
102. High-Sensitivity C-Reactive Protein Complements Plasma Epstein-Barr Virus Deoxyribonucleic Acid Prognostication in Nasopharyngeal Carcinoma: A Large-Scale Retrospective and Prospective Cohort Study
103. Nonmuscle myosin heavy chain IIA mediates Epstein–Barr virus infection of nasopharyngeal epithelial cells
104. How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection
105. Classifying the tumor microenvironment to stratify nasopharyngeal carcinoma patients
106. SPECT and Near-Infrared Fluorescence Imaging of Breast Cancer with a Neuropilin-1-Targeting Peptide
107. Pathogenesis and Etiology of Nasopharyngeal Carcinoma
108. Development of a nomogram to predict overall survival among non-metastatic breast cancer patients in China: a retrospective multicenter study
109. Correction to: Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
110. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways
111. Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
112. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines
113. Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2
114. Prophylactic vaccines against Epstein–Barr virus
115. Discovering broader antiviral strategies: Role of interferon-induced transmembrane proteins in virus infection
116. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
117. High hepatitis B virus infection in B-cell lymphoma tissue and its potential clinical relevance
118. Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
119. Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses
120. A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo
121. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma
122. Additional file 1 of A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
123. TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma
124. EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties
125. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma
126. EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Formation
127. Correction: Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein–Barr virus infection
128. Corrigendum to: Heat shock factor 1 upregulates transcription of Epstein–Barr Virus nuclear antigen 1 by binding to a heat shock element within the BamHI-Q promoter [Virology 421 (2011) 184–191]
129. Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
130. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma
131. Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study
132. Expression and clinical significance of SIAH in laryngeal squamous cell carcinoma
133. EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity
134. The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
135. Additional file 2 of The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma
136. Additional file 1 of The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma
137. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution
138. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
139. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma
140. Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection
141. Dendritic cells modified with 6Ckine/IFNγ fusion gene induce specific cytotoxic T lymphocytes in vitro
142. Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice
143. Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
144. Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway
145. A potent and protective human neutralizing antibody targeting a key vulnerable site of Epstein-Barr Virus
146. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
147. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma
148. Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein–Barr virus infection
149. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
150. R9AP is a functional receptor for Epstein-Barr virus infection in both epithelial cells and B cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.